Varegacestat

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameVaregacestat
Drug Alias NameAL-102BMS-986115WHG-626
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid precursor protein secretases inhibitors
TargetsAmyloid precursor protein secretases
Therapy Area/IndicationsHepatic InsufficiencyFibromatosis, AggressiveNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active IndicationsHepatic InsufficiencyFibromatosis, Aggressive
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A